Education
About Us
Working with TipRanks
Follow Us
Chugai Pharmaceutical Co Ltd (CHGCF)
OTHER OTC:CHGCF
RESEARCH TOOLSreports
Total Valuation
Chugai Pharmaceutical Co has a market cap or net worth of $76.97B. The enterprise value is $10.53T.
Market Cap$76.97B
Enterprise Value$10.53T
Share Statistics
Chugai Pharmaceutical Co has 1.68B shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1.68B
Owened by Insiders
Owened by Instutions0.08%
Financial Efficiency
Chugai Pharmaceutical Co’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 20.16%.
Return on Equity (ROE)20.37%
Return on Assets (ROA)17.54%
Return on Invested Capital (ROIC)20.16%
Return on Capital Employed (ROCE)28.26%
Revenue Per Employee$150,313,448.187
Profits Per Employee$49,801,619.954
Employee Count7,778
Asset Turnover0.53
Inventory Turnover1.41
Valuation Ratios
The current PE Ratio of Chugai Pharmaceutical Co is 29.73. Chugai Pharmaceutical Co’s PEG ratio is 1.57.
PE Ratio29.73
PS Ratio9.84
PB Ratio6.06
Price to Fair Value6.06
Price to FCF29.03
Price to Operating Cash Flow25.73
PEG Ratio1.57
Income Statement
In the last 12 months, Chugai Pharmaceutical Co had revenue of $1.17T and earned $387.36B in profits. Earnings per share was $235.38.
Revenue$1.17T
Gross Profit$829.73B
Operating Income$545.33B
Pretax Income$543.03B
Net Income$387.36B
EBITDA567.41B
Earnings Per Share (EPS)235.38
Cash Flow
In the last 12 months, operating cash flow was $449.79B and capital expenditures -$52.62B, giving a free cash flow of $397.17B billion.
Operating Cash Flow$449.79B
Free Cash Flow$397.17B
Free Cash Flow per Share$236.55
Dividends & Yields
Chugai Pharmaceutical Co pays an annual dividend of $0.52, resulting in a dividend yield of 1.49%
Dividend Per Share$0.52
Dividend Yield1.49%
Payout Ratio24.21%
Free Cash Flow Yield3.44%
Earnings Yield3.36%
Stock Price Statistics
Beta0.61
52-Week Price Change25.42%
50-Day Moving Average45.99
200-Day Moving Average44.39
Relative Strength Index (RSI)51.84
Average Volume (3m)4.00K
Important Dates
Chugai Pharmaceutical Co upcoming earnings date is Apr 24, 2025, Before Open.
Last Earnings DateJan 30, 2025
Next Earnings DateApr 24, 2025
Ex-Dividend DateJun 26, 2025
Financial Position
Chugai Pharmaceutical Co as a current ratio of 5.53, with Debt / Equity ratio of 0.00
Current Ratio5.53
Quick Ratio4.70
Debt to Market Cap0.00
Net Debt to EBITDA-0.95
Interest Coverage Ratio-527.75
Taxes
In the past 12 months, Chugai Pharmaceutical Co has paid $155.67B in taxes.
Income Tax$155.67B
Effective Tax Rate28.68%
Enterprise Valuation
Chugai Pharmaceutical Co EV to EBITDA ratio is 19.31, with an EV/FCF ratio of 27.67.
EV to Sales9.38
EV to EBITDA19.31
EV to Free Cash Flow27.67
EV to Operating Cash Flow24.52
Balance Sheet
Chugai Pharmaceutical Co has $996.35B in cash and marketable securities with $0.00 in debt, giving a net cash position of -$996.35B billion.
Cash & Marketable Securities$996.35B
Total Debt$0.00
Net Cash-$996.35B
Net Cash Per Share-$593.40
Tangible Book Value Per Share$1.14K
Margins
Gross margin is 71.01%, with operating margin of 46.30%, and net profit margin of 33.09%.
Gross Margin71.01%
Operating Margin46.30%
Pretax Margin46.39%
Net Profit Margin33.09%
EBITDA Margin48.55%
EBIT Margin46.30%
Analyst Forecast
The average price target for Chugai Pharmaceutical Co is $49.47, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$49.47
Price Target Upside19.38%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast